Condition: Atrial Fibrillation · Atrial Arrhythmia · Atrial Flutter · Sponsor: Tulane University
The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize that patients with a higher baseline Utah fibrosis staging will experience a higher incidence of POAF. The study also aims to evaluate and compare the in-hospital mortality, length-of-stay (LOS), complication rates (strokes, pneumonia, respiratory failure etc.) of the different Utah fibrosis stage cohorts. Perform cost analysis and compare between patients with POAF and patients without POAF. The investigators hypothesize that patients experiencing POAF will have a higher mortality rate, longer LOS, greater complications, and therefore, additional hospital costs.
This description comes directly from the study's public registry record.
Yara Menassa, MD · 504-316-2003 · ymenassa@tulane.edu
Kunal Sameer, MD, MHA · 504-988-3072 · ksameer@tulane.edu
Always discuss trial participation with your own doctor first.
| Lakeview Hospital | Covington, Louisiana, United States | Recruiting |
| East Jefferson General Hospital | New Orleans, Louisiana, United States | Recruiting |
| Washington University Barnes-Jewish Hospital | St Louis, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05014802